Isis Innovation Company Profile

18:09 EST 12th December 2018 | BioPortfolio

Isis Innovation is the technology transfer company of the University of Oxford, commercialising the research generated by University researchers and owned by the University.Isis Innovation Ltd is a wholly-owned subsidiary of the University of Oxford; it was established in 1988 and in 1997 started a major expansion phase. The University assigns its intellectual property to Isis (where there are no pre-existing exploitation arrangements) and Isis then evaluates, protects, and markets the intellectual property. In 2002, Oxford University Consulting became part of Isis, matching business consulting needs with University researchers.


Ewert House, Ewert Place
United Kingdom


Phone: 44 (0)1865 280830
Fax: 44 (0)1865 280831

News Articles [372 Associated News Articles listed on BioPortfolio]

Isis Innovation: How the Oxford Sciences Innovation fund is promoting investment in the Oxfordshire region

Adam Stoten, head of Technology Transfer at Isis Innovation (the technology transfer arm of the University of Oxford) discusses the recent successes of Oxford Sciences Innovation (OSI), a fund compris...

US$ 1.5B Deal, PTV News: Apr 01, 2010

GSK and Isis to develop up to 6 drugs for rare and serious diseases

Cholesterol Hope, PTV News: Mar 18, 2010

Genzyme and Isis announce positive phase III trials for inherited high LDL drug

News Headlines, PTV News: Apr 01, 2010

A look at today's forthcoming news stories: GSK and Isis in US$ 1.5B deal to develop rare disease drugs; sanofi changes direction towards biotechnology, and Glaxo gets approval for Avodart in combinat...

Has Innovation Just Become An Infectious Disease?

There's a epidemic of innovation out there. The cure might be an "innovation strategy" against the burden of creativity that can plague purpose, process and people.

2018 Innovation and Entrepreneurship Fair was Held to Boost Innovation and Entrepreneurship ...

International, professional and marketing level of the Innovation and Entrepreneurship Fair is continuously improving and is becoming the powerful drive to implement the innovation-driven developmen...

News Headlines, PTV News: Mar 18, 2010

A look at today's forthcoming news stories including Genzyme and Isis announcing positive trials for rare cholesterol condition; Novartis wins European approval for meningitis vaccine and the cannabis...

The Secret To Innovation Is The Lightning Rod, Not The Lightning

Beyond stating innovation in your mission statement, corporations must actively reach out and connect with the mixed and varied voices of innovation to be successful.

PubMed Articles [251 Associated PubMed Articles listed on BioPortfolio]

Injury and death during the ISIS occupation of Mosul and its liberation: Results from a 40-cluster household survey.

Measurement of mortality and injury in conflict situations presents many challenges compared with stable situations. However, providing information is important to assess the impact of conflict on pop...

Truck attack: Fear of ISIS and reminder of truck attacks in Europe as associated with psychological distress and PTSD symptoms.

Following an ISIS attack, the present study examined the association between psychological distress and severe stress symptoms with vulnerability variables: i.e. Physical proximity to the site of the ...

Can scalar timing explain variability in scanning patterns?

Why are scanning patterns so variable? Theory predicts that for prey species facing non-stalking predators scans to monitor predators should occur at fixed rather than unpredictable times. Yet, empiri...

Innovation in the Context of Audiology and in the Context of the Internet.

This article explores different meanings of innovation within the context of audiology and the Internet. Case studies are used to illustrate and elaborate on the new types of innovation and their leve...

The 'full stack' of healthcare innovation skills: combining clinical informatics with care delivery innovation.

Clinical Trials [193 Associated Clinical Trials listed on BioPortfolio]

A Double Blind, Placebo-Controlled, Dose-Escalation, Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of ISIS 353512 Administered Intravenously and Subcutaneously to Healthy Volunteers

The purpose of this study is to evaluate the safety and tolerability of single and multiple doses of ISIS 353512, to evaluate the blood concentration and rate elimination of ISIS 353512 fr...

Dose-Escalating Safety Study in Subjects on Stable Statin Therapy

The aim of this study is to assess the safety of varying doses of ISIS 301012 in subjects on Stable statin therapy.

Study of ISIS 301012 in Heterozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy

The aim of this study is to assess the safety and efficacy of varying doses of ISIS 301012 as add-on therapy in subjects with Heterozygous Familial Hypercholesterolemia

The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes

To evaluate the efficacy and safety of ISIS 2922 in AIDS patients with Cytomegalovirus ( CMV ) retinitis who are unresponsive or intolerant to ganciclovir and/or foscarnet but are otherwis...

A Study of Multiple Doses of ISIS SMNRx (ISIS 396443) Delivered to Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy

The primary objective of the study is to examine the efficacy of multiple doses of ISIS SMNRx (ISIS 396443) administered intrathecally in preventing or delaying the need for respiratory in...

Companies [977 Associated Companies listed on BioPortfolio]

Isis Innovation

Isis Innovation is the technology transfer company of the University of Oxford, commercialising the research generated by University researchers and owned by the University.Isis Innovation Ltd is a wh...

Isis Parenting Inc.

Isis Parenting is the nation’s leading provider of prenatal and early parenting education. Isis partners with leading healthcare institutions to offer over their patients ove...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

Isis Pharmaceuticals

Isis Pharmaceuticals, Inc. is a leading drug discovery and development company, focused exclusively on the therapeutic target, RNA. Founded in 1989, Isis' mission is to develop products from its RNA-b...

Isis Pharmaceuticals, Inc.

More Information about "Isis Innovation" on BioPortfolio

We have published hundreds of Isis Innovation news stories on BioPortfolio along with dozens of Isis Innovation Clinical Trials and PubMed Articles about Isis Innovation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Isis Innovation Companies in our database. You can also find out about relevant Isis Innovation Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record